DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 02 · Volume 55 · 1986 DOI: 10.1055/s-009-45128

Original Article

  • 153
  • 158
  • 162
  • 168
  • 173
  • 178
  • 184
  • 189
  • 194
  • 197
  • 201
  • 206
  • 213
  • 218
    Fischer, A M; Cornu, P; Sternberg, C; Mériane, F; Dautzenberg, M D; Chafa, O; Beguin, S; Desnos, M:

    Antithrombin III Alger: A New Homozygous AT III Variant

  • 222
  • 228
  • 235
    Wallin, R; Susan, D; Patrick, D; Ballard, J O:

    Vitamin K Antagonism of Coumarin Intoxication in the Rat

  • 240
  • 246
  • 250
  • 259
  • 263
    Aihara, M; Sawada, Y; Ueno, K; Morimoto, S; Yoshida, Y; Serres, M de; Copper, H A; Wegner, R H:

    Visualization of von Willebrand Factor Multimers by Immunoenzymatic Stain Using Avidin-Biotin Peroxidase Complex

  • 268
  • 271
    Ireland, Helen; Lane, D A; Flynn, Angela; Anastassiades, E; Curtis, J R:

    The Anticoagulant Effect of Heparinoid Org 10172 During Haemodialysis: An Objective Assessment

  • 276
  • 279
  • International Committee Communications

  • 282
  • Letter to the Editor

  • 292
    Llopis, F; González-Molina, A; Aznar, J A; Jorquera, J I; Carmona, E; Villanueva, M J; Trenor, A; Sánchez-Cuenca, J M:

    Auto-Antibodies in Haemophilia A and B

  • 293
  • 294
  • 296
  • 297
    Kariya, K; Aihara, K; Ueno, A; Kimura, A; Yoshida, Y:

    Von Willebrand Factor and Major Blood Groups in Japan

  • 298
  • 299
    Richard, C; Sedano, C; Cuadrado, M A; Iriondo, A; Bello, C; Gandarillas, M A; Zubizarreta, A:

    Effect of a Thymic Factor on the Concentration of a Factor VIII Inhibitor in a Patient with Treated Hodgkin’s Disease

  • 301
    Henny, Ch P; Cate, H ten; Cate, J W ten; Prummel, M F; Peters, M; Büller, H R:

    Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid

  • 302
    Cruickshank, Dr. Alexander M:

    Gordon Research Conference on Hemostasis